ENSURE: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study

MesoPher (autologous dendritic cell vaccine) - Erasmus MC, Amphera

https://oncologypro.esmo.org/meeting-resources/esmo-congress/ensure-dendritic-cell-therapy-mesopher-in-combination-with-extended-pleurectomy-decortication-after-chemotherapy-in-subjects-with-resectable-mes

L. Cantini1; M.V. Dietz1; R.A. Belderbos1; R. Cornelissen1; D.W. Dumoulin1; M. Vink1; K. Bezemer1; A.W. Langerak2; J. von der Thüsen3; E.A.F. Mahtab4; L.P.W.M. Maat4; R. Stadhouders1; R. Hendriks1; M. Willemsen1; J.G. Aerts1

Jul 28, 2022